Relationship between three palliative care outcome scales

Health and Quality of Life Outcomes

Nora Donaldson¹  Irene J Higginson¹ 

[1] Department of Palliative Care and Policy, King's College London, Weston Education Centre, Cutcombe Road, London SE5 9RJ, UK

关键词: day care;    hospice;    symptoms;    hope;    assessment;    quality of life;    palliative care;   

Others  :  1216921
DOI  :  10.1186/1477-7525-2-68

 received in 2004-10-06, accepted in 2004-11-29,  发布年份 2004

【 摘 要 】

Background

Various scales have been used to assess palliative outcomes. But measurement can still be problematic and core components of measures have not been identified. This study aimed to determine the relationships between, and factorial structure of, three widely used scales among advanced cancer patients.

Methods

Patients were recruited who received home or hospital palliative care services in the south of England. Hope, quality of life and palliative outcomes were assessed by patients in face to face interviews, using three previously established scales – a generic measure (EQoL), a palliative care specific measure (POS) and a measure of hope (Herth Hope Index). Analysis comprised: exploratory factor analysis of each individual scale, and all scales combined, and confirmatory factor analysis for model building and validation.

Results

Of 171 patients identified, 140 (81%) consented and completed first interviews; mean age was 71 years, 54% were women, 132 had cancer. In exploratory analysis of individual means, three out of the five factors in the EQoL explained 75% of its variability, four out of the 10 factors in POS explained 63% of its variability, and in the Hope Index, nine out of the 12 items explained 69% of its variability. When exploring the relative factorial structure of all three scales, five factors explained 56% of total combined variability. Confirmatory analysis reduced this to a model with four factors – self-sufficiency, positivity, symptoms and spiritual. Removal of the spiritual factor left a model with an improved goodness of fit and a measure with 11 items.

Conclusion

We identified three factors which are important outcomes and would be simple to measure in clinical practice and research.

【 授权许可】

   
2004 Higginson and Donaldson; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Bottomley A, Efficace F, Thomas R, Vancoorden V, Ahmedzai SH: Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials. J Clin Oncol 2003, 21:2982-2992.
• [2]Levine MN, Ganz PA: Beyond the development of quality-of-life instruments: where do we go from here? J Clin Oncol 2002, 20:2215-2216.
• [3]Higginson IJ, Carr AJ: Measuring quality of life: Using quality of life measures in the clinical setting. BMJ 2001, 322:1297-1300.
• [4]McMillan SC, Weitzner MA: Methodologic issues in collecting data from debilitated patients with cancer near the end of life. Oncol Nurs Forum 2003, 30:123-129.
• [5]Rustoen T, Fossa SD, Skarstein J, Moum T: The impact of demographic and disease-specific variables on pain in cancer patients. J Pain Symptom Manage 2003, 26:696-704.
• [6]Hahn EA, Cella D: Health outcomes assessment in vulnerable populations: measurement challenges and recommendations. Arch Phys Med Rehabil 2003, 84:S35-S42.
• [7]Di Maio M, Perrone F: Quality of life in elderly patients with cancer. Health and Quality of Life Outcomes 2003, 1:44. BioMed Central Full Text
• [8]Hearn J, Higginson IJ: Outcome measures in palliative care for advanced cancer patients: a review. J Public Health Med 1997, 19:193-199.
• [9]Cohen SR, Mount BM, Tomas JJN, Mount LF: Existential well-being is an important determinant of quality of life: Evidence from the McGill Quality of Life Questionnaire. Cancer 1996, 77:576-586.
• [10]Spitzer WO, Dobson AL, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR: Measuring the quality of life of cancer patients: a concise QL- Index for use by physicans. J Chron Dis 1980, 34:585-597.
• [11]Kaasa S, Loge JH: Quality of life in palliative care: principles and practice. Palliat Med 2003, 17:11-20.
• [12]Steinhauser KE, Bosworth HB, Clipp EC, McNeilly M, Christakis NA, Parker J, Tulsky JA: Initial assessment of a new instrument to measure quality of life at the end of life. Journal of Palliative Medicine 2002, 5:829-841.
• [13]Brazier J, Jones N, Kind P: Testing the validity of the EuroQoL and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993, 2:169-180.
• [14]Kind P, Dolan P, Gudex C, Williams A: Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998, 316:736-741.
• [15]Van Agt H, Essink-Bot ML, Krabbe P, Bonsel G: Test re-test reliability of health state valuations collected with the EuroQoL questionnaire. Soc Sci Med 1994, 39:1537-1544.
• [16]Hurst NP, Jobanputra P, Hunter M, Lambert M, Lochead A, Brown H: Validity of EuroQoL - a generic health status instrument - in patients with rheumatoid arthritis. British Journal of Rheumatology 1994, 33:656-662.
• [17]Aspinal F, Hughes R, Higginson IJ, Chidgey J, Drescher U, Thompson M: A user's guide to the Palliative Outcome Scale. London , Palliative Care and Policy Publications; 2002.
• [18]Hearn J, Higginson IJ: Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Quality in Health Care 1999, 8:219-227.
• [19]Herth K: Hope in the family caregiver of terminally ill people. J Adv Nurs 1993, 18:538-548.
• [20]Bentler PM: EQS: Structural Equations Manual. Los Angeles, BMDP Statistical Software; 1989.
• [21]Dunn G, Everitt B, Pickles A: Modelling Covariances and Latent Variables using EQS. Chapman and Hall ; 1993.
• [22]Dolan P: Modelling valuations for EuroQoL health states. Medical Care 1997, 35:1095-1108.
• [23]Johnson JA, Coons SJ, Ergo A, Szava-Kovats G: Valuation of EuroQoL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 1998, 13:421-433.
• [24]Franks P, Lubetkin EI, Gold MR, Tancredi DJ, Jia H: Mapping the SF-12 to the EuroQoL EQ-5D index in a national US sample. Medical Decision Making 2004, 24:247-254.
• [25]Khayat D: Quality of life: It's never too late. J Clin Oncol 2002, 20:2915-2917.
• [26]Higginson IJ, Costantini M: Communication in end-of-life cancer care: a comparison of team assessments in three European countries. J Clin Oncol 2002, 20:3674-3682.
• [27]King M, Speck P, Thomas A: The Royal Free Interview for religious and spiritual beliefs: development and standardization. Psychol Med 1995, 25:1125-1134.
• [28]McClain CS, Rosenfeld B, Breitbart W: Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet 2003, 361:1603-1607.
• [29]Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny H, Norton L, al : The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer 1994, 30A:1326-1336.
• [30]Modi S, Panageas KS, Duck ET, Bach A, Weinstock N, Dougherty J, Cramer L, Hudis C, Norton L, Seidman A: Prospective explanatory analysis of the association between tumour response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer. J Clin Oncol 2002, 20:3665-3673.
• [31]Sherry KL, McAuley G: Symptom prevalence and the use of systematic symptom assessment. Palliat Med 2004, 18:75-76.
• [32]Higginson IJ, Wade AM, McCarthy M: Effectiveness of two palliative support teams. J Public Health Med 1992, 14:50-56.
• [33]Gysels M, Higginson IJ: Improving supportive and palliative care for adults with cancer: Research Evidence. [http://www.nice.org.uk/pdf/csgsresearchevidence.pdf] webciteLondon, National Institute of Clinical Excellence; 2004.
• [34]Harding R, Higginson IJ: What is the best way to help caregivers in cancer and palliative care? A systematic review of interventions and their effectiveness. Palliat Med 2003, 17:63-74.